Daniel Pereira Monteiro: Welcome to the Haemopaedia Case of the Week!
Daniel Pereira Monteiro, NHSE Screening Professional Clinical Advisor, shared a post on LinkedIn:
“Welcome to the Haemopaedia Case of the Week – Answer and Learning points related to my previous post.
Great comments and interpretations, well done to all!
In this video, I go through the importance of each detail and how it is considered for haemoglobinopathy interpretation, but also any further actions required related to antenatal screening.
Let me know in the comments section if you found it useful and what case/topic you would like me to discuss, so I can plan a case of the week for it
If you’d like to receive updates about upcoming training sessions, webinars and case-based learning, you can join my Training Hub list here.
You can unsubscribe at any time
Have a case you’d like featured? DM me to share an anonymised example for future posts.
Bio-Rad Laboratories
Institute of Biomedical Science
Disclaimer:
All cases shared in these series are for educational purposes only and do not constitute clinical or diagnostic advice.
Contributors are reminded to ensure all examples are fully anonymised and shared in accordance with their local governance and confidentiality policies.”
Discover the latest in Hemostasis Today.
-
Sep 5, 2026, 16:08Indre Ceponiene: Major Gaps in Secondary Cardiovascular Prevention Across Europe
-
Sep 5, 2026, 16:03W. Alberto Sifuentes Giraldo: Why Obstetric Cases Are Missed Under 2023 ACR/EULAR APS Criteria
-
Sep 5, 2026, 15:58Srikanth Nalla: A Case of Saddle Pulmonary Embolism
-
Sep 5, 2026, 15:55COPD-specific Pulmonary Embolism Diagnostic Strategy – Thrombosis and Haemostasis
-
Sep 5, 2026, 15:41Sam Tsimikas on Lp(a) HORIZON Topline Results – What Missed Endpoints Mean for Cardiovascular Risk
-
Sep 5, 2026, 15:32Stefano Garzon: SELUTION DeNovo HBR – Weren’t HBR Patients Supposed to Bleed More with DES?
-
Sep 5, 2026, 15:24Mayer Hany: Recombinant Activated FVII in Spontaneous Intracerebral Hemorrhage
-
Sep 5, 2026, 15:09Consuela A. Albright: Clinical Advocacy in Sickle Cell Disease
-
Sep 5, 2026, 15:00Brandon Buck: Human Cell-Free DNA as a Diagnostic Tool for Aging and Rare Blood Disorders